|
Volumn 15, Issue 15, 2005, Pages 3576-3579
|
A macromolecular prodrug of doxorubicin conjugated to a biodegradable cyclotriphosphazene bearing a tetrapeptide
|
Author keywords
Antitumor agent; Doxorubicin; Phosphazene trimer; Tetrapeptide
|
Indexed keywords
CYCLOTRIPHOSPHAZENE;
CYCLOTRIPHOSPHAZENE DOXORUBICIN CONJUGATE;
CYTOTOXIC AGENT;
DOXORUBICIN;
DOXORUBICIN DERIVATIVE;
GLYCYLPHENYLALANYLLEUCYLGLYCINE;
MACROGOL 350;
MACROGOL DERIVATIVE;
METHOXYPOLY(ETHYLENE GLYCOL);
TETRAPEPTIDE;
UNCLASSIFIED DRUG;
ARTICLE;
COMPARATIVE STUDY;
CONTROLLED STUDY;
CYTOTOXICITY;
DERIVATIZATION;
DRUG ACTIVITY;
DRUG CONJUGATION;
DRUG SOLUBILITY;
DRUG STRUCTURE;
DRUG SYNTHESIS;
ENZYME RELEASE;
HUMAN;
HUMAN CELL;
HYDROPHILICITY;
IN VITRO STUDY;
LEUKEMIA CELL LINE;
MACROMOLECULE;
MOLECULAR WEIGHT;
ANIMALS;
ANTIBIOTICS, ANTINEOPLASTIC;
BIODEGRADATION, ENVIRONMENTAL;
CELL LINE, TUMOR;
DOXORUBICIN;
INHIBITORY CONCENTRATION 50;
LEUKEMIA L1210;
MAGNETIC RESONANCE SPECTROSCOPY;
MOLECULAR WEIGHT;
NITRILES;
OLIGOPEPTIDES;
PHOSPHORUS COMPOUNDS;
POLYETHYLENE GLYCOLS;
PRODRUGS;
STEREOISOMERISM;
|
EID: 21744449145
PISSN: 0960894X
EISSN: None
Source Type: Journal
DOI: 10.1016/j.bmcl.2005.05.057 Document Type: Article |
Times cited : (24)
|
References (26)
|